Circadian Reset Technology for Binge Eating Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether new virtual reality (VR) technology can assist people with binge eating disorder by improving sleep and controlling appetite. Participants will use a VR headset twice daily for a month. One group will use a special circadian reset technology (CRT), while the other will use a regular VR program as a control. Individuals diagnosed with binge eating disorder who feel their eating habits affect their daily life might be a good fit. The researchers hope that better sleep will lead to better control over eating habits. As an unphased trial, this study offers a unique opportunity to explore innovative technology that could enhance quality of life.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this circadian reset technology is safe for individuals with binge eating disorder?
Research shows that specific safety data for Circadian Reset Technology (CRT) is not yet available. However, CRT aims to help manage sleep patterns, which is generally safe. This trial involves using a VR headset for short daily sessions, likely making it easy to handle. Since CRT does not involve medication or medical procedures, it typically has fewer side effects. Participants in similar studies have not reported major problems. The use of VR and light in CRT is expected to be safe, but individuals sensitive to light or prone to motion sickness should exercise caution.12345
Why are researchers excited about this trial?
Researchers are excited about Circadian Reset Technology for treating Binge Eating Disorder because it leverages the body's internal clock to potentially regulate eating behaviors. Unlike standard treatments like cognitive behavioral therapy or medications that target neurotransmitters, this technology uses a non-invasive VR headset to influence circadian rhythms directly. The unique delivery method involves brief, twice-daily sessions that aim to reset the body's natural cycles, offering a novel, drug-free approach that could lead to improved outcomes with minimal side effects.
What evidence suggests that Circadian Reset Technology is effective for binge eating disorder?
Research shows that the body's internal clock, known as circadian rhythms, might be connected to binge eating disorder. Studies have found that individuals with this disorder often eat more and experience stronger food cravings at specific times of the day. In this trial, participants will use Circadian Reset Technology (CRT), designed to enhance these rhythms, potentially aiding in better sleep and control over eating habits. By using a VR headset with CRT software, the goal is to reduce binge eating by resetting these internal clocks. Early results suggest that improving sleep and rhythm regulation could lead to fewer binge eating episodes.12678
Who Is on the Research Team?
Tom Hildebrandt
Principal Investigator
Icahn School of Medicine at Mount Sinai
Are You a Good Fit for This Trial?
This trial is for individuals with binge eating disorder. Participants will use a VR headset twice daily for a month. They must not have other conditions that could interfere with the study or be using treatments that affect sleep and eating behaviors.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening/Baseline
Participants are screened for eligibility to participate in the trial
Treatment
Participants use a VR headset twice daily for 5 minutes each session over 1 month. Weekly online surveys and daily EMA surveys are conducted.
Follow-up
Participants are monitored for changes in binge eating frequency, sleep quality, and other secondary outcomes.
What Are the Treatments Tested in This Trial?
Interventions
- Circadian Reset Technology
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor